Triple therapy with PPI-amoxicillin-clarithromycin for H-pylori eradication: The optimal regimen in 1996

被引：0
|
作者：
Lamouliatte, H [1 ]
Cayla, R [1 ]
Zerbib, F [1 ]
Talbi, P [1 ]
Megraud, F [1 ]
deMascarel, A [1 ]
机构：
[1] HOP ST ANDRE, F-33075 BORDEAUX, FRANCE
来源：
GASTROENTEROLOGY | 1996年 / 110卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A171 / A171
页数：1
相关论文
共 50 条
  • [21] Dual Therapy with Vonoprazan and Amoxicillin Is as Effective as Triple Therapy with Vonoprazan, Amoxicillin and Clarithromycin for Eradication of Helicobacter pylori
    Furuta, Takahisa
    Yamade, Mihoko
    Kagami, Takuma
    Uotani, Takahiro
    Suzuki, Takahiro
    Higuchi, Tomohiro
    Tani, Shinya
    Hamaya, Yasushi
    Iwaizumi, Moriya
    Miyajima, Hiroaki
    Umemura, Kazuo
    Osawa, Satoshi
    Sugimoto, Ken
    DIGESTION, 2020, 101 (06) : 743 - 751
  • [22] Dual therapy with vonoprazan and amoxicillin is as effective as triple therapy with vonoprazan, amoxicillin and clarithromycin for eradication of Helicobacter pylori
    Furuta, T.
    Yamade, M.
    Kagami, T.
    Suzuki, T.
    Higuchi, T.
    Uotani, T.
    Tani, S.
    Iwaizumi, M.
    Hamaya, Y.
    Osawa, S.
    Sugimoto, K.
    HELICOBACTER, 2019, 24
  • [23] Rifabutin based triple therapy for eradication of H-pylori primary and secondary resistant to tinidazole and clarithromycin
    Toracchio, S
    Capodicasa, S
    Soraja, DB
    Cellini, L
    Marzio, L
    DIGESTIVE AND LIVER DISEASE, 2005, 37 (01) : 33 - 38
  • [24] 7-day triple triple with esomeprazole, amoxicillin and clarithromycin for H-pylori (H P) eradication in duodenal ulcer (DU) disease.
    van Zanten, SJV
    Lauritsen, K
    Delchier, JC
    Labenz, J
    de Argila, CM
    Lind, T
    Treichel, HC
    Stubberod, A
    Cockeran, AW
    Hasselgren, G
    Gothe, L
    Wrangstadh, M
    GASTROENTEROLOGY, 2000, 118 (04) : A503 - A503
  • [25] Treatment Success With Dual Proton Pump Inhibitor Plus Amoxicillin H. pylori Therapy or PPI, Amoxicillin, Clarithromycin Triple Therapy
    Graham, David Y.
    Javed, Syed U.
    Keihanian, Sara
    Abudayyeh, Suhaib
    Opekun, Antone R.
    GASTROENTEROLOGY, 2010, 138 (05) : S468 - S468
  • [26] Comparison of triple rabeprazole/metronidazole/sitafloxacin therapy versus triple rabeprazole/amoxicillin/sitafloxacin therapy as the 3rd rescue regimen for eradication of H-pylori
    Furuta, T.
    Sugimoto, M.
    Kodaira, C.
    Nishino, M.
    Yamade, M.
    Uotani, T.
    HELICOBACTER, 2010, 15 (04) : 338 - 338
  • [27] Roxithromycine in triple therapy for H-pylori eradication.
    Dammann, HG
    Bilke, R
    Burkhardt, F
    Wolf, N
    Walter, TA
    GASTROENTEROLOGY, 1996, 110 (04) : A90 - A90
  • [28] WHEN STANDARD TRIPLE THERAPY WITH PPI plus AMOXICILLIN plus CLARITHROMYCIN FAILS IN THE ERADICATION OF HELICOBACTER PYLORI, WHAT'S NEXT?
    Marin, A. C.
    McNicholl, A. G.
    Gisbert, J. P.
    HELICOBACTER, 2012, 17 : 100 - 100
  • [29] The effect of MDR1 C3435T polymorphism on the eradication rates of H-pylori by a triple therapy with lansoprazole, clarithromycin and amoxicillin
    Furuta, Takahisa
    Shirai, Naohito
    Sugimoto, Mitsushige
    Nakamura, Akiko
    Ikuma, Mutsuhiro
    Kajimura, Masayoshi
    Hishida, Akira
    GASTROENTEROLOGY, 2006, 130 (04) : A573 - A573
  • [30] When Standard Triple Therapy With PPI plus Amoxicillin plus Clarithromycin Fails in the Eradication of Helicobacter pylori, What's Next?
    Marin, Alicia C.
    McNicholl, Adrian G.
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2013, 144 (05) : S333 - S333
12345